Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Idenix Pharmaceuticals Shares Surged: What You Need to Know
Motley Fool
Saturday, December 3, 2011 - 3:54pm
tags:
Idenix, IDX184, hepatitis C
One More Thought About Lipitor
Forbes
Saturday, December 3, 2011 - 3:53pm
tags:
Pfizer, Lipitor
The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc.
Yahoo/PR NewsWire
Saturday, December 3, 2011 - 3:51pm
tags:
Abbott Laboratories, lawsuits
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Forbes
Saturday, December 3, 2011 - 3:50pm
tags:
Spectrum Pharmaceuticals, Zevalin, non-Hodgkin's lymphoma, osteosarcoma, Fusilev
Watson Pharma Going Strong
Yahoo/Zacks
Saturday, December 3, 2011 - 11:14am
tags:
Watson
Faruqi & Faruqi, LLP Announces Investigation of Pacific Biosciences of California, Inc.
Yahoo/BusinessWire
Saturday, December 3, 2011 - 11:13am
tags:
Pacific Biosciences, lawsuits
Rigrodsky & Long, P.A. Announces Its Investigation of Possible Violations of the Federal Securities Laws by Pacific Biosciences of California, Inc.
Yahoo/BusinessWire
Saturday, December 3, 2011 - 11:12am
tags:
Pacific Biosciences, lawsuits
December Catalysts for Drug and Biotech Stocks
Minyanville
Saturday, December 3, 2011 - 11:11am
tags:
Pfizer, Aveo Pharmaceutical, Affymax, Amgen, Antares Pharma, Celgene, ONYX Pharmaceuticals, Seattle Genetics, Micromet, YM BioSciences, Regeneron, BioSante
Pomerantz Reminds Shareholders of Human Genome Sciences, Inc. of Upcoming Deadline -- HGSI
Yahoo/GlobeNewswire
Saturday, December 3, 2011 - 11:08am
tags:
Human Genome Sciences, lawsuits
Medicis Announces Close of Graceway Acquisition
Yahoo/GlobeNewswire
Saturday, December 3, 2011 - 11:07am
tags:
Medicis, Graceway, M&A
Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout
Seeking Alpha
Saturday, December 3, 2011 - 11:06am
tags:
Savi, Krystexxa, gout
PDL BioPharma About To Put More Money In Your Pocket
Forbes
Saturday, December 3, 2011 - 11:03am
tags:
PDL Biopharma
Northwest Bio Implements Major Balance Sheet Clean-Up
Yahoo/PR NewsWire
Saturday, December 3, 2011 - 11:03am
tags:
Northwest Biotherapeutics
Biotech Stock Mailbag: Affymax
The Street
Saturday, December 3, 2011 - 11:01am
tags:
Affymax
Teva May Get ‘Free Money’ From Ranbaxy’s Lipitor Copy Sales
Bloomberg Businessweek
Friday, December 2, 2011 - 12:12pm
tags:
Lipitor, generics, Pfizer, Ranbaxy, Teva Pharmaceuticals
Teva v. Astrazeneca: Invalidating a patent with secret prior art
Patently
Friday, December 2, 2011 - 12:08pm
tags:
Teva Pharmaceuticals, AstraZeneca, patents
Big Pharma struggles to protect its blockbusters as they lose patent protection
The Economist
Friday, December 2, 2011 - 12:07pm
tags:
Big Pharma, patent cliff, patents, generics
Sanofi spikes authorized Lovenox generic
Fierce Pharma
Friday, December 2, 2011 - 12:06pm
tags:
Sanofi, Lovenox, bloodthinners, Sandoz, generics, Amphastar
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Yahoo/AP
Friday, December 2, 2011 - 12:04pm
tags:
Bristol-Myers Squibb, JNJ, hepatitis C, daclatasvir, TMC435
Hospira Now Takeover Target Amid FDA Scrutiny
Bloomberg
Friday, December 2, 2011 - 11:26am
tags:
Hospira, M&A, FDA, Teva Pharmaceuticals, Fresenius

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.